LGALS1 promotes the malignant progression and sunitinib resistance of clear cell renal cell carcinoma by reprogramming fatty acid metabolism
- DOI
- 10.1016/j.intimp.2026.117038
- Published
- 2026-09
- Container
- International Immunopharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117038,
title = {LGALS1 promotes the malignant progression and sunitinib resistance of clear cell renal cell carcinoma by reprogramming fatty acid metabolism},
author = {Sichen Di and Tong Wu and Ji Liu and Shuai Liu and Keqiang Li and Wei Yang and Wenjin Chen and Qiwei Yang and Guangchun Wang and Xudong Yao and Haimin Zhang},
year = {2026},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2026.117038},
url = {https://doi.org/10.1016/j.intimp.2026.117038}
}RIS
TY - JOUR TI - LGALS1 promotes the malignant progression and sunitinib resistance of clear cell renal cell carcinoma by reprogramming fatty acid metabolism AU - Sichen Di AU - Tong Wu AU - Ji Liu AU - Shuai Liu AU - Keqiang Li AU - Wei Yang AU - Wenjin Chen AU - Qiwei Yang AU - Guangchun Wang AU - Xudong Yao AU - Haimin Zhang PY - 2026 JO - International Immunopharmacology DO - 10.1016/j.intimp.2026.117038 UR - https://doi.org/10.1016/j.intimp.2026.117038 ER -
APA
Di, S., Wu, T., Liu, J., Liu, S., Li, K., Yang, W., Chen, W., Yang, Q., Wang, G., Yao, X., & Zhang, H. (2026). LGALS1 promotes the malignant progression and sunitinib resistance of clear cell renal cell carcinoma by reprogramming fatty acid metabolism. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117038
Source records
- crossref · retrieved 2026-09-26T21:48:32.107Z